Advanced Search
Contact | Corporate | Help

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Sponsors:
  • National Surgical Adjuvant Breast and Bowel Project (NSABP)
  • Genentech
  • US Oncology Research
Phases:
  • Phase III
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: bevacizumab
  • Drug: docetaxel
  • Drug: doxorubicin
  • Drug: cyclophosphamide
  • Drug: cyclophosphamide
  • Drug: pegfilgrastim
Enrollment:
3900

Additional information about NCT00887536.


SourceSolution © 2008-2012